🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study will be a double-blind, randomized, crossover, single-dose assess...
Status
Completed
Location
Nucleus Network Limited
Start Date
2017-09-25
Trial ID
NCT03194139
Treatments Being Tested
The purpose of the phase 3, clinical study is to determine if GC4419 (avaso...
Status
Completed
Location
Banner MD Anderson Cancer Center
Start Date
2018-10-03
Trial ID
NCT03689712
Treatments Being Tested
The purpose of the phase 2, GT-201 clinical study is to determine if GC4419...
Status
Completed
Location
University of Arizona Cancer Center at Dignity Health St. Joseph's
Start Date
2015-10-12
Trial ID
NCT02508389
GC4419 is being studied to treat and prevent oral mucositis (painful inflam...
Status
Completed
Location
Celerion
Start Date
2017-08-14
Trial ID
NCT03163173
Treatments Being Tested
The study is a two-center, Phase 1, open-label, single-dose, one-period, fo...
Status
Completed
Location
Inventiv Health Clinical -Research Pharmacy Unit
Start Date
2019-04-04
Trial ID
NCT05412472
Treatments Being Tested
This study aims to evaluate the safety of avasopasem in combination with CD...
Status
Recruiting
Location
Mays Cancer Center, UT Health San Antonio
Start Date
2025-10-02
Trial ID
NCT07137871
Treatments Being Tested
GTI-4419-202 is a Phase 2 open-label study of the effects of GC4419 (IV) wh...
Status
Completed
Location
Onze-Lieve-Vrouwziekenhuis (OLVZ) - Campus Aalst
Start Date
2020-06-30
Trial ID
NCT04529850
Treatments Being Tested
The purpose of this study is to determine the safety, tolerability, and the...
Status
Completed
Location
Lakeland Regional Cancer Center
Start Date
2013-08
Trial ID
NCT01921426
Treatments Being Tested
GTI-4419-203 will be an open-label, multi-center study to evaluate GC4419 (...
Status
Terminated
Location
Banner MD Anderson Cancer Center
Start Date
2019-12-19
Trial ID
NCT04225026
Treatments Being Tested
This will be a single center, phase 1, open-label, fixed-sequence study und...
Status
Completed
Location
Inventiv Health Clinical - Research Pharmacy Unit
Start Date
2019-02-10
Trial ID
NCT03792971
Treatments Being Tested